For more than two years, we have been preparing for a variety of Brexit scenarios and have taken the necessary steps, in collaboration with our partners, to help ensure that patients in the UK have ongoing access to our medicines.
In addition to following the stockpile guidance issued by the Government, Janssen has gone above and beyond by:
Moving products intended for the UK market to dedicated UK distribution centres, to minimise the impact of possible border delays
Identifying and implementing alternative distribution routes to avoid potential delays at the Calais/Folkstone ports
Sourcing additional warehouse space to accommodate these extra medicines now located in the UK
Despite the ongoing uncertainty, Janssen will continue to do everything within our control to minimise any Brexit-related interruption to the supply of our medicines, for patients and their families in the UK
Job Code: CP-111305 Date of preparation: September 2019